Efficacy and Tolerability of a Chemically Characterized Scutellaria lateriflora L. Extract-Based Food Supplement for Sleep Management: A Single-Center, Controlled, Randomized, Crossover, Double-Blind Clinical Trial
Abstract
In a randomized crossover double-blind placebo-controlled trial in 66 subjects with mild-to-moderate primary insomnia, a Scutellaria lateriflora L. extract (400 mg/day) significantly improved Pittsburgh Sleep Quality Index scores, sleep onset latency, efficiency and total sleep time, with no adverse effects.
Referenced for these plants
How to cite
Di Minno, A., Morone, M.V., Buccato, D.G., De Lellis, L.F. and others (2025) 'Efficacy and Tolerability of a Chemically Characterized Scutellaria lateriflora L. Extract-Based Food Supplement for Sleep Management: A Single-Center, Controlled, Randomized, Crossover, Double-Blind Clinical Trial', Nutrients, 17(9), pp. 1491. doi:10.3390/nu17091491
This reference is part of the evidence base for the Omnia Sana plant database. Source links open the original publication; Omnia Sana does not host third-party content.